{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "06020992",
    "validDate": "2025-05-04 00:00:00.000",
    "issueDate": "2010-05-04 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00602099200",
    "prodNameC": "\"貝克曼庫爾特\" 乾式廣效性乙內醯胺每確認檢驗組",
    "prodNameE": "\"Beckman Coulter\" MicroScan ESBL plus ESBL Confirmation Panel",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "Antimicrobial Agents\tAbbr.\t[μg\/ml*]\\n1. Aztreonam \tAzt \t0.5-64\\n2. Cefepime \tCpe \t1-32\\n3. Cefotaxime \tCft \t0.5-128\\n4. Cefotaxime\/ K Clavulanate\tCft\/CA \t0.12\/4-16\/4\\n5. Cefotetan \tCtn \t1-32\\n6. Cefoxitin \tCfx \t2-32\\n7. Cefpodoxime \tCpd \t0.5-64\\n8. Ceftazidime \tCaz \t0.5-128\\n9. Ceftazidime\/ K Clavulanate\tCaz\/CA \t0.12\/4-16\/4\\n10. Ceftriaxone \tCax \t1-64\\n11. Imipenem \tImp \t0.5-16\\n12. Meropenem \tMer \t0.5-16\\n13. Piperacillin \tPi \t16-64\\n* After rehydration with 115 μl.\t\t\\n"
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "美商貝克曼庫爾特有限公司台灣分公司",
    "applicantAddr": "台北市大安區敦化南路二段216號8樓",
    "medClass": "2",
    "efficacy": "用於決定生長於固態培養基之快速成長革蘭氏陰性桿菌菌落對抗生素之感受性，以及偵測大腸桿菌(Escherichia coli)、產酸克雷伯氏菌(Klebsiella oxytoca)、肺炎克雷伯氏桿菌(Klebsiella pneumoniae)與奇異變型桿菌(Proteus mirabilis)是否產生廣效性乙內醯胺每(ESBL)之用。 ",
    "mdFormat": "B1027-101 (20 tests)",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "C",
            "mdKindMCodeName": "C 免疫學及微生物學裝置",
            "mdKindDCode": "C.1645",
            "mdKindDCodeName": "C.1645 全自動短孵育期抗生素感受性試驗系統",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "BECKMAN COULTER INC.",
            "factoryAddr": "2040 Enterprise Blvd. West Sacramento, CA95691, USA",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MUS1131000",
            "factoryInfo": "1",
            "qsd": "QSD4235"
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Antimicrobial Agents\tAbbr.\t[μg\/ml*]\\n1. Aztreonam \tAzt \t0.5-64\\n2. Cefepime \tCpe \t1-32\\n3. Cefotaxime \tCft \t0.5-128\\n4. Cefotaxime\/ K Clavulanate\tCft\/CA \t0.12\/4-16\/4\\n5. Cefotetan \tCtn \t1-32\\n6. Cefoxitin \tCfx \t2-32\\n7. Cefpodoxime \tCpd \t0.5-64\\n8. Ceftazidime \tCaz \t0.5-128\\n9. Ceftazidime\/ K Clavulanate\tCaz\/CA \t0.12\/4-16\/4\\n10. Ceftriaxone \tCax \t1-64\\n11. Imipenem \tImp \t0.5-16\\n12. Meropenem \tMer \t0.5-16\\n13. Piperacillin \tPi \t16-64\\n* After rehydration with 115 μl.\t\t\\n",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [
        {
            "fileType": "2",
            "fileName": "06020992001___20121214.pdf",
            "fileStreamId": "9541D0B4-EF0F-4F52-942C-63E94788B453"
        },
        {
            "fileType": "1",
            "fileName": "06020992001___20121214.pdf",
            "fileStreamId": "5D2CE451-F766-4A1F-B5C0-9FC0659F42D2"
        }
    ],
    "changeDtoList": [],
    "atcList": []
}